KALRAY SADIR (ALKAL.PA) Fundamental Analysis & Valuation

EPA:ALKAL • FR0010722819

Current stock price

8.34 EUR
+2.32 (+38.54%)
Last:

This ALKAL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALKAL.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALKAL has reported negative net income.
  • ALKAL had a negative operating cash flow in the past year.
  • In the past 5 years ALKAL always reported negative net income.
  • ALKAL had negative operating cash flow in 4 of the past 5 years.
ALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

  • ALKAL's Return On Assets of -21.36% is on the low side compared to the rest of the industry. ALKAL is outperformed by 95.45% of its industry peers.
  • Looking at the Return On Equity, with a value of -42.95%, ALKAL is doing worse than 96.97% of the companies in the same industry.
Industry RankSector Rank
ROA -21.36%
ROE -42.95%
ROIC N/A
ROA(3y)-19.53%
ROA(5y)-23.68%
ROE(3y)-41.1%
ROE(5y)-44.77%
ROIC(3y)N/A
ROIC(5y)N/A
ALKAL.PA Yearly ROA, ROE, ROICALKAL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

  • The Gross Margin of ALKAL (123.33%) is better than 100.00% of its industry peers.
  • ALKAL's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALKAL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 123.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.53%
GM growth 5Y-27.47%
ALKAL.PA Yearly Profit, Operating, Gross MarginsALKAL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ALKAL.PA Health Analysis

2.1 Basic Checks

  • ALKAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALKAL has been increased compared to 1 year ago.
  • ALKAL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALKAL has a worse debt to assets ratio.
ALKAL.PA Yearly Shares OutstandingALKAL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALKAL.PA Yearly Total Debt VS Total AssetsALKAL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of 1.14, we must say that ALKAL is in the distress zone and has some risk of bankruptcy.
  • ALKAL's Altman-Z score of 1.14 is on the low side compared to the rest of the industry. ALKAL is outperformed by 89.39% of its industry peers.
  • ALKAL has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.15, ALKAL perfoms like the industry average, outperforming 59.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACCN/A
WACC12.3%
ALKAL.PA Yearly LT Debt VS Equity VS FCFALKAL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • ALKAL has a Current Ratio of 0.66. This is a bad value and indicates that ALKAL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALKAL's Current ratio of 0.66 is on the low side compared to the rest of the industry. ALKAL is outperformed by 96.97% of its industry peers.
  • A Quick Ratio of 0.55 indicates that ALKAL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.55, ALKAL is doing worse than 95.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.55
ALKAL.PA Yearly Current Assets VS Current LiabilitesALKAL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALKAL.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.89% over the past year.
  • ALKAL shows a small growth in Revenue. In the last year, the Revenue has grown by 1.40%.
  • ALKAL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.37% yearly.
EPS 1Y (TTM)50.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.21%
Revenue 1Y (TTM)1.4%
Revenue growth 3Y157.5%
Revenue growth 5Y81.37%
Sales Q2Q%-27.77%

3.2 Future

  • Based on estimates for the next years, ALKAL will show a very strong growth in Earnings Per Share. The EPS will grow by 27.15% on average per year.
  • Based on estimates for the next years, ALKAL will show a very strong growth in Revenue. The Revenue will grow by 45.29% on average per year.
EPS Next Y72.16%
EPS Next 2Y38.1%
EPS Next 3Y27.15%
EPS Next 5YN/A
Revenue Next Year-32.52%
Revenue Next 2Y-18.6%
Revenue Next 3Y-6.95%
Revenue Next 5Y45.29%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALKAL.PA Yearly Revenue VS EstimatesALKAL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
ALKAL.PA Yearly EPS VS EstimatesALKAL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALKAL.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALKAL. In the last year negative earnings were reported.
  • Also next year ALKAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKAL.PA Price Earnings VS Forward Price EarningsALKAL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALKAL.PA Per share dataALKAL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALKAL's earnings are expected to grow with 27.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.1%
EPS Next 3Y27.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALKAL.PA Dividend Analysis

5.1 Amount

  • No dividends for ALKAL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALKAL.PA Fundamentals: All Metrics, Ratios and Statistics

KALRAY SADIR

EPA:ALKAL (4/28/2026, 7:00:00 PM)

8.34

+2.32 (+38.54%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A
Earnings (Next)07-09
Inst Owners4.1%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap128.52M
Revenue(TTM)21.79M
Net Income(TTM)-14.28M
Analysts42.5
Price Target1.53 (-81.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)200%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.9
P/FCF N/A
P/OCF N/A
P/B 3.87
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-2.41
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.41
BVpS2.16
TBVpS-0.67
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -21.36%
ROE -42.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 123.33%
FCFM N/A
ROA(3y)-19.53%
ROA(5y)-23.68%
ROE(3y)-41.1%
ROE(5y)-44.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.53%
GM growth 5Y-27.47%
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 175.99%
Cap/Sales 153.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.55
Altman-Z 1.14
F-Score3
WACC12.3%
ROIC/WACCN/A
Cap/Depr(3y)126.32%
Cap/Depr(5y)90.91%
Cap/Sales(3y)102.68%
Cap/Sales(5y)192.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.21%
EPS Next Y72.16%
EPS Next 2Y38.1%
EPS Next 3Y27.15%
EPS Next 5YN/A
Revenue 1Y (TTM)1.4%
Revenue growth 3Y157.5%
Revenue growth 5Y81.37%
Sales Q2Q%-27.77%
Revenue Next Year-32.52%
Revenue Next 2Y-18.6%
Revenue Next 3Y-6.95%
Revenue Next 5Y45.29%
EBIT growth 1Y17.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.27%
EBIT Next 3Y36.76%
EBIT Next 5YN/A
FCF growth 1Y-153.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1903.89%
OCF growth 3YN/A
OCF growth 5YN/A

KALRAY SADIR / ALKAL.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for KALRAY SADIR?

ChartMill assigns a fundamental rating of 2 / 10 to ALKAL.PA.


Can you provide the valuation status for KALRAY SADIR?

ChartMill assigns a valuation rating of 1 / 10 to KALRAY SADIR (ALKAL.PA). This can be considered as Overvalued.


What is the profitability of ALKAL stock?

KALRAY SADIR (ALKAL.PA) has a profitability rating of 1 / 10.